Close Menu

NEW YORK (GenomeWeb) – Invitae reported after the close of the market Wednesday a 169 percent increase in first quarter revenues driven by 150 percent growth in testing volume.

"We are poised to become the leading provider of inherited genetic testing services in the next 12 to 18 months," said CEO Sean George in a conference call to discuss the financial results.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.